These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 38711082)
1. DCAF1 interacts with PARD3 to promote hepatocellular carcinoma progression and metastasis by activating the Akt signaling pathway. Zhang J; Shi Y; Ding K; Yu W; He J; Sun B J Exp Clin Cancer Res; 2024 May; 43(1):136. PubMed ID: 38711082 [TBL] [Abstract][Full Text] [Related]
2. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway. Tang L; Xu S; Wei R; Fan G; Zhou J; Wei X; Xu X Mol Med; 2024 Jul; 30(1):108. PubMed ID: 39060928 [TBL] [Abstract][Full Text] [Related]
3. VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway. Zhangyuan G; Wang F; Zhang H; Jiang R; Tao X; Yu D; Jin K; Yu W; Liu Y; Yin Y; Shen J; Xu Q; Zhang W; Sun B Oncogene; 2020 Feb; 39(6):1213-1230. PubMed ID: 31605014 [TBL] [Abstract][Full Text] [Related]
4. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma. Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-1468 promotes tumor progression by activating PPAR-γ-mediated AKT signaling in human hepatocellular carcinoma. Liu Z; Wang Y; Dou C; Sun L; Li Q; Wang L; Xu Q; Yang W; Liu Q; Tu K J Exp Clin Cancer Res; 2018 Mar; 37(1):49. PubMed ID: 29510736 [TBL] [Abstract][Full Text] [Related]
6. CD73 promotes hepatocellular carcinoma progression and metastasis via activating PI3K/AKT signaling by inducing Rap1-mediated membrane localization of P110β and predicts poor prognosis. Ma XL; Shen MN; Hu B; Wang BL; Yang WJ; Lv LH; Wang H; Zhou Y; Jin AL; Sun YF; Zhang CY; Qiu SJ; Pan BS; Zhou J; Fan J; Yang XR; Guo W J Hematol Oncol; 2019 Apr; 12(1):37. PubMed ID: 30971294 [TBL] [Abstract][Full Text] [Related]
7. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway. Gao J; Dai C; Yu X; Yin XB; Zhou F J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108 [TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
9. Carboxypeptidase A6 Promotes the Proliferation and Migration of Hepatocellular Carcinoma by Up-regulating AKT Signaling Pathway. Huang QB; Zhang HW; Liao ZB Curr Med Sci; 2019 Oct; 39(5):727-733. PubMed ID: 31612389 [TBL] [Abstract][Full Text] [Related]
10. Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma. Wang J; Xia C; Pu M; Dai B; Yang X; Shang R; Yang Z; Zhang R; Tao K; Dou K Oncol Rep; 2018 Oct; 40(4):1875-1884. PubMed ID: 30015982 [TBL] [Abstract][Full Text] [Related]
11. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway. Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514 [No Abstract] [Full Text] [Related]
12. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma. Liu Z; Wang Y; Wang L; Yao B; Sun L; Liu R; Chen T; Niu Y; Tu K; Liu Q J Exp Clin Cancer Res; 2019 May; 38(1):194. PubMed ID: 31088485 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway. Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399 [TBL] [Abstract][Full Text] [Related]
14. Down-regulated lncRNA TP73-AS1 reduces radioresistance in hepatocellular carcinoma via the PTEN/Akt signaling pathway. Song W; Zhang J; Xia Q; Sun M Cell Cycle; 2019 Nov; 18(22):3177-3188. PubMed ID: 31564201 [No Abstract] [Full Text] [Related]
15. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway. Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122 [TBL] [Abstract][Full Text] [Related]
16. NCSTN promotes hepatocellular carcinoma cell growth and metastasis via β-catenin activation in a Notch1/AKT dependent manner. Li H; Lan T; Xu L; Liu H; Wang J; Li J; Chen X; Huang J; Li X; Yuan K; Zeng Y; Wu H J Exp Clin Cancer Res; 2020 Jul; 39(1):128. PubMed ID: 32631394 [TBL] [Abstract][Full Text] [Related]
17. APLN promotes hepatocellular carcinoma through activating PI3K/Akt pathway and is a druggable target. Chen H; Wong CC; Liu D; Go MYY; Wu B; Peng S; Kuang M; Wong N; Yu J Theranostics; 2019; 9(18):5246-5260. PubMed ID: 31410213 [No Abstract] [Full Text] [Related]
18. PSMD9 promotes the malignant progression of hepatocellular carcinoma by interacting with c-Cbl to activate EGFR signaling and recycling. Su Y; Meng L; Ge C; Liu Y; Zhang C; Yang Y; Tian W; Tian H J Exp Clin Cancer Res; 2024 May; 43(1):142. PubMed ID: 38745188 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway. Dong X; Wang F; Xue Y; Lin Z; Song W; Yang N; Li Q Int J Mol Med; 2019 Mar; 43(3):1417-1429. PubMed ID: 30664155 [TBL] [Abstract][Full Text] [Related]
20. MEG2 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting AKT pathway. Ying D; Ruan Y; Zhou X Gene; 2019 Mar; 687():1-8. PubMed ID: 30399427 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]